Loading...
Merck Serono announces license agreement with Auxogyn
07-Apr-2014
- Germany
Advertisement
Merck Serono announced an exclusive license agreement with Auxogyn, Inc., Menlo Park, California, USA, a company dedicated to advancing women’s reproductive health, for Auxogyn’s proprietary Early Embryo Viability Assessment (Eeva®) Test.